Show simple item record

dc.contributor.authorHjortshøj, Søren
dc.contributor.authorOtterstad, Jan Erik
dc.contributor.authorLindahl, Bertil
dc.contributor.authorDanielsen, Ragnar
dc.contributor.authorPulkki, Kari
dc.contributor.authorRavkilde, Jan
dc.date.accessioned2010-11-15T10:02:56Z
dc.date.available2010-11-15T10:02:56Z
dc.date.issued2005-07-01
dc.date.submitted2010-11-15
dc.identifier.citationScand. Cardiovasc. J. 2005, 39(3):159-66en
dc.identifier.issn1401-7431
dc.identifier.pmid16146978
dc.identifier.doi10.1080/14017430510009140
dc.identifier.urihttp://hdl.handle.net/2336/115561
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractOBJECTIVES: To investigate the diagnostic approach in Nordic hospitals receiving patients suspected of acute myocardial infarction (MI), especially focusing on implementation of the recently proposed criteria by the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) for the definition of MI. DESIGN: A survey with questionnaires of the diagnostic approach was conducted among all relevant departments (220) in the Nordic countries. RESULTS: Seventy-six percent (167) of hospitals responded. Troponins I and T (TnI and TnT) and creatinine kinase monobasic fraction (mass concentration) (CKMB(mass)) covered 93 and 65% of hospitals, respectively. Of troponin users, 34% indicated use of TnI vs 66% using TnT. Sporadic use of AST, CK, LD and myoglobin was reported. There was a tendency to lower cut-off levels in Sweden and Finland. Among troponin assays, there was considerable heterogeneity regarding cut-off levels. CONCLUSIONS: The Nordic countries are approaching ESC/ACC consensus on cardiac markers. Compared with previous national surveys (1995-1999), there is a shift towards the use of troponins. However, differences in cut-off levels of troponin emphasize the need for harmonization of assays.
dc.language.isoenen
dc.publisherInforma Healthcareen
dc.relation.urlhttp://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=17472555&site=ehost-liveen
dc.subject.meshBiological Markersen
dc.subject.meshConsensusen
dc.subject.meshDenmarken
dc.subject.meshEmergency Service, Hospitalen
dc.subject.meshFinlanden
dc.subject.meshHealth Care Surveysen
dc.subject.meshHumansen
dc.subject.meshIcelanden
dc.subject.meshLaboratory Techniques and Proceduresen
dc.subject.meshMyocardial Infarctionen
dc.subject.meshNorwayen
dc.subject.meshPractice Guidelines as Topicen
dc.subject.meshQuestionnairesen
dc.subject.meshSwedenen
dc.titleBiochemical diagnosis of myocardial infarction evolves towards ESC/ACC consensus: experiences from the Nordic countriesen
dc.typeArticleen
dc.contributor.departmentCardiovascular Research Center and Department of Cardiology, Aalborg Hospital, Denmarken
dc.identifier.journalScandinavian cardiovascular journal : SCJen
html.description.abstractOBJECTIVES: To investigate the diagnostic approach in Nordic hospitals receiving patients suspected of acute myocardial infarction (MI), especially focusing on implementation of the recently proposed criteria by the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) for the definition of MI. DESIGN: A survey with questionnaires of the diagnostic approach was conducted among all relevant departments (220) in the Nordic countries. RESULTS: Seventy-six percent (167) of hospitals responded. Troponins I and T (TnI and TnT) and creatinine kinase monobasic fraction (mass concentration) (CKMB(mass)) covered 93 and 65% of hospitals, respectively. Of troponin users, 34% indicated use of TnI vs 66% using TnT. Sporadic use of AST, CK, LD and myoglobin was reported. There was a tendency to lower cut-off levels in Sweden and Finland. Among troponin assays, there was considerable heterogeneity regarding cut-off levels. CONCLUSIONS: The Nordic countries are approaching ESC/ACC consensus on cardiac markers. Compared with previous national surveys (1995-1999), there is a shift towards the use of troponins. However, differences in cut-off levels of troponin emphasize the need for harmonization of assays.


This item appears in the following Collection(s)

Show simple item record